Document is current
Any future updates will be listed below
-
Authors
Wang, Shirley B. https://orcid.org/0000-0002-8583-3014
Van Genugten, Ruben D. I.
Yacoby, Yaniv https://orcid.org/0000-0002-0421-1070
Pan, Weiwei
Bentley, Kate H.
Bird, Suzanne A.
Buonopane, Ralph J.
Christie, Alexis
Daniel, Merryn
DeMarco, Dylan
Haim, Adam
Follet, Lia
Fortgang, Rebecca G.
Kelly-Brunyak, Flynn
Kleiman, Evan M.
Millner, Alexander J.
Obi-Obasi, Onyinye
Onnela, J. P.
Ramlal, Narise
Ricard, Jordyn R. https://orcid.org/0000-0001-5039-0455
Smoller, Jordan W.
Tambedou, Tida
Zuromski, Kelly L.
Nock, Matthew K.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (F31MH125495, K23MH120436, K23MH132766, R01MH117599, K23MH120439, U01MH116928)
- License Information
-
More Information
Article History
Received: 10 May 2023
Accepted: 19 September 2024
First Online: 24 October 2024
Competing interests
: M.K.N. receives publication royalties from Macmillan, Pearson and UpToDate. He has been a paid consultant in the past three years for Microsoft Corporation, the Veterans Health Administration and COMPASS Pathways, and for legal cases regarding a death by suicide. He has stock options in Cerebral Inc. He is an unpaid scientific advisor for Empatica, Koko and TalkLife. E.M.K. has been a paid consultant in the past three years for Boehringer Ingelheim Pharmaceuticals. J.W.S. is a member of the Scientific Advisory Board of Sensorium Therapeutics (with equity), and has received grant support from Biogen, Inc. He is PI of a collaborative study of the genetics of depression and bipolar disorder sponsored by 23andMe for which 23andMe provides analysis time as in-kind support but no payments. J.P.O. has been a paid consultant in the past three years for Boehringer Ingelheim and has received research funding from them. D.D. is the founder and CEO of Apoth.
